These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29865088)

  • 21. LG2 agrin mutation causing severe congenital myasthenic syndrome mimics functional characteristics of non-neural (z-) agrin.
    Maselli RA; Fernandez JM; Arredondo J; Navarro C; Ngo M; Beeson D; Cagney O; Williams DC; Wollmann RL; Yarov-Yarovoy V; Ferns MJ
    Hum Genet; 2012 Jul; 131(7):1123-35. PubMed ID: 22205389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A class of chemical compounds enhances clustering of muscle nicotinic acetylcholine receptor in cultured myogenic cells.
    Miyairi Y; Ohkawara B; Sato A; Sawada R; Ishii H; Tomita H; Inoue T; Nakashima H; Ito M; Masuda A; Hosono Y; Imagama S; Ohno K
    Biochem Biophys Res Commun; 2024 Oct; 731():150400. PubMed ID: 39024975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK.
    Gallenmüller C; Müller-Felber W; Dusl M; Stucka R; Guergueltcheva V; Blaschek A; von der Hagen M; Huebner A; Müller JS; Lochmüller H; Abicht A
    Neuromuscul Disord; 2014 Jan; 24(1):31-5. PubMed ID: 24183479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
    Koneczny I; Cossins J; Waters P; Beeson D; Vincent A
    PLoS One; 2013; 8(11):e80695. PubMed ID: 24244707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of nerve- versus muscle-derived factors in mammalian neuromuscular junction formation.
    Lin S; Landmann L; Ruegg MA; Brenner HR
    J Neurosci; 2008 Mar; 28(13):3333-40. PubMed ID: 18367600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.
    Tsao CY
    Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial Dok7 congenital myasthenic syndrome responsive to salbutamol.
    Maramattom BV; Patil R; Thomas J
    Neurol India; 2014; 62(3):313. PubMed ID: 25033858
    [No Abstract]   [Full Text] [Related]  

  • 28. SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody.
    Huda S; Cao M; De Rosa A; Woodhall M; Rodriguez Cruz PM; Cossins J; Maestri M; Ricciardi R; Evoli A; Beeson D; Vincent A
    Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31831571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapsyn facilitates recovery from desensitization in fetal and adult acetylcholine receptors expressed in a muscle cell line.
    Cetin H; Liu W; Cheung J; Cossins J; Vanhaesebrouck A; Maxwell S; Vincent A; Beeson D; Webster R
    J Physiol; 2019 Jul; 597(14):3713-3725. PubMed ID: 31158924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.
    Burke G; Hiscock A; Klein A; Niks EH; Main M; Manzur AY; Ng J; de Vile C; Muntoni F; Beeson D; Robb S
    Neuromuscul Disord; 2013 Feb; 23(2):170-5. PubMed ID: 23219351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel SEA and LG2 Agrin mutations causing congenital Myasthenic syndrome.
    Xi J; Yan C; Liu WW; Qiao K; Lin J; Tian X; Wu H; Lu J; Wong LJ; Beeson D; Zhao C
    Orphanet J Rare Dis; 2017 Dec; 12(1):182. PubMed ID: 29258548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mutation in DOK7 in congenital myasthenic syndrome forms aggresome in cultured cells, and reduces DOK7 expression and MuSK phosphorylation in patient-derived iPS cells.
    Zhang S; Ohkawara B; Ito M; Huang Z; Zhao F; Nakata T; Takeuchi T; Sakurai H; Komaki H; Kamon M; Araki T; Ohno K
    Hum Mol Genet; 2023 Apr; 32(9):1511-1523. PubMed ID: 36579833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuregulin inhibits acetylcholine receptor aggregation in myotubes.
    Trinidad JC; Cohen JB
    J Biol Chem; 2004 Jul; 279(30):31622-8. PubMed ID: 15155732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.
    Ohkawara B; Cabrera-Serrano M; Nakata T; Milone M; Asai N; Ito K; Ito M; Masuda A; Ito Y; Engel AG; Ohno K
    Hum Mol Genet; 2014 Apr; 23(7):1856-68. PubMed ID: 24234652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sialic acid inhibits agrin signaling in C2 myotubes.
    Grow WA; Gordon H
    Cell Tissue Res; 2000 Feb; 299(2):273-9. PubMed ID: 10741468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Src-family kinases stabilize the neuromuscular synapse in vivo via protein interactions, phosphorylation, and cytoskeletal linkage of acetylcholine receptors.
    Sadasivam G; Willmann R; Lin S; Erb-Vögtli S; Kong XC; Rüegg MA; Fuhrer C
    J Neurosci; 2005 Nov; 25(45):10479-93. PubMed ID: 16280586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathophysiological characterization of congenital myasthenic syndromes: the example of mutations in the MUSK gene].
    Chevessier F; Faraut B; Ravel-Chapuis A; Richard P; Gaudon K; Bauché S; Prioleau C; Herbst R; Goillot E; Ioos C; Azulay JP; Attarian S; Leroy JP; Fournier E; Legay C; Schaeffer L; Koenig J; Fardeau M; Eymard B; Pouget J; Hantaï D
    J Soc Biol; 2005; 199(1):61-77. PubMed ID: 16114265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of ACh receptor clustering by the tyrosine phosphatase Shp2.
    Zhao XT; Qian YK; Chan AW; Madhavan R; Peng HB
    Dev Neurobiol; 2007 Nov; 67(13):1789-801. PubMed ID: 17659592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up.
    Durmus H; Shen XM; Serdaroglu-Oflazer P; Kara B; Parman-Gulsen Y; Ozdemir C; Brengman J; Deymeer F; Engel AG
    Neuromuscul Disord; 2018 Apr; 28(4):315-322. PubMed ID: 29395675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrosine phosphatase regulation of MuSK-dependent acetylcholine receptor clustering.
    Madhavan R; Zhao XT; Ruegg MA; Peng HB
    Mol Cell Neurosci; 2005 Mar; 28(3):403-16. PubMed ID: 15737732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.